BIAFW 8-K 2026-11-06

bioAffinity Technologies, Inc. (BIAFW) 8-K dated 2026-11-06 — accession 0001493152-26-050541.

bioAffinity Technologies, Inc. (BIAFW) warrant listed on US.

bioAffinity Technologies, Inc. filed a 8-K on 2026-11-06. Accession 0001493152-26-050541.

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported BIAFW revenue for 2025-12-31 was $6.2M. Net income was -$14.9M. Revenue was down 34.2% from 2024-12-31 to 2025-12-31. BIAFW currently screens at market cap $1.7M.

Not investment advice. The BIAFW SEC hub lists recent forms. The stock page is the research view.